66. IgA腎症 IgA nephropathy Clinical trials / Disease details

臨床試験数 : 275 / 薬物数 : 258 - (DrugBank : 82) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 140

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02187900 (ClinicalTrials.gov)	June 2014	22/6/2014	Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f.	Phase 3 Study of Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f	IgA Nephropathy	Drug: Multi-glycoside of Tripterygium Wilfordii HOOK. f. (TWH);Drug: Mycophenolate mofetil (MMF)	Second Xiangya Hospital of Central South University	NULL	Recruiting	16 Years	65 Years	Both	300	Phase 3	China
2	NCT00657059 (ClinicalTrials.gov)	September 2007	8/4/2008	Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)	A Prospective, Multicenter, Randomized Controlled Trial of Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)	IgA Nephropathy	Drug: irbesartan;Drug: methylprednisolone (MP) or prednisone (pred);Drug: mycophenolate mofetil (MMF)	Sun Yat-sen University	NULL	Completed	14 Years	60 Years	All	151	Phase 3	China
3	NCT00318474 (ClinicalTrials.gov)	January 2002	24/4/2006	Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy	A Randomized Controlled Trial of Mycophenolate Mofetil in Patients With IgA Nephropathy	IgA Nephropathy	Drug: Mycophenolate Mofetil (MMF);Drug: MMF Placebo;Drug: ACEi;Drug: FOS	St. Joseph's Hospital and Medical Center, Phoenix	NULL	Terminated	7 Years	70 Years	All	184	Phase 3	United States